U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06826716) titled 'A Study to Assess the Effect of Libifem(R) (VL-GF-01) on Fertility in Women With Diminished Ovarian Reserve' on Dec. 17, 2024.
Brief Summary: The present study is a randomized, double-blind, placebo-controlled, parallel clinical study. Approximately 156 participants will be screened, and considering a screening failure rate of 20%, not more than 124 participants will be randomized in a ratio of 1:1 to receive either Libifem(R) or placebo and will be assigned a unique randomization code. Each group will have not less than 50 completed participants after accounting for a dropout/withdrawal rate of 20%.
Study Start Date: Feb. 10
Stud...